Dynavax Technologies (DVAX) halted ahead of FDA adcom
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Medifast launches Trilivy, replacing its Optavia brand
Dynavax (DVAX) Resumes Trading, Shares Down 60%+
November 15, 2012 4:33 PM ESTDynavax Technologies Corporation (NASDAQ: DVAX) shares resume trading, shares are down over 60 percent.... More
Dynavax (DVAX) to Resume Trading at 4:30PM ET
November 15, 2012 4:10 PM ESTDynavax Technologies Corporation (NASDAQ: DVAX) is scheduled to resume trading at 4:30PM ET after an FDA panel voted against Heplisav for Heb B... More
Dynavax (DVAX) Fails to Win FDA Panel Backing on Heplisav for Hep B
November 15, 2012 1:52 PM ESTFDA advisors vote 8-5 that Dynavax Technologies Corporation (NASDAQ: DVAX) Heplisav vaccine unsafe as Hep B treatment. The panel said the vaccine hasn't shown enough safety.
Shares of Dynavax are currently halted.... More
Jefferies Says Dynavax (DVAX) Briefing Documents Bode Well For Panel
November 14, 2012 10:30 AM ESTJefferies reiterated its Buy rating and $6 price target on Dynavax Technologies (NASDAQ: DVAX) following yesterday's FDA briefing documents Heplisav.
The documents, according to Jefferies' analyst Thomas Wei, "suggesting a mostly benign stance by the FDA, which concluded that there were no imbalances in... More
FDA Says Dynavax's (DVAX) Heplisav as Safe as Glaxo's (GSK) Engerix-B; Shares Pop
November 13, 2012 12:29 PM ESTDynavax (Nasdaq: DVAX) is higher as its heplisav is seen as safe as Glaxo's (NYSE: GSK) Engerix-B by the U.S. FDA.
The data comes from an FDA briefing document ahead of a November 15th... More
